Insights

Expanding Diagnostic Portfolio Diasorin's recent launch of advanced diagnostic assays such as the CE-marked LIAISON QuantiFERON-TB Gold Plus II and the Legionella Urinary Antigen Immunodiagnostic Assay indicates a focus on expanding their portfolio in infectious disease testing, presenting opportunities to target healthcare providers seeking comprehensive testing solutions.

Strategic Acquisitions The acquisition of Luminex Network Intelligence Group and subsequent asset sales demonstrate Diasorin’s strategic expansion in multiplex and flow cytometry diagnostics, creating cross-selling opportunities with clients interested in integrated diagnostic platforms.

Global Research Investment With over 400 researchers and ten R&D centers worldwide, Diasorin actively innovates and enhances its testing capabilities, making it a promising partner for laboratories and healthcare institutions seeking cutting-edge diagnostic technologies.

Regional Market Expansion New hires and regional sales management appointments, such as in Ireland, indicate ongoing efforts to deepen market penetration across Europe and other continents, making local sales efforts potentially more effective in targeted regions.

Technology and Digital Tools The robust tech stack, including Oracle ERP and social intelligence tools, suggests that Diasorin utilizes advanced digital solutions to streamline operations and customer engagement, providing avenues for integrated sales strategies and digital outreach to healthcare providers.

Diasorin Group Tech Stack

Diasorin Group uses 8 technology products and services including Open Graph, WordPress, Oracle ERP, and more. Explore Diasorin Group's tech stack below.

  • Open Graph
    Content Management System
  • WordPress
    Content Management System
  • Oracle ERP
    Enterprise
  • Bomgar
    Identity And Access Management
  • Social Intelligence
    Pre-employment Assessment
  • JSON
    Programming Languages
  • Minitab
    Visualisation Software
  • Apache HTTP Server
    Web Servers

Media & News

Diasorin Group's Email Address Formats

Diasorin Group uses at least 1 format(s):
Diasorin Group Email FormatsExamplePercentage
First.Last@diasorin.comJohn.Doe@diasorin.com
95%
FirstLast@diasorin.comJohnDoe@diasorin.com
3%
First.MiddleLast@diasorin.comJohn.MichaelDoe@diasorin.com
1%
First@diasorin.comJohn@diasorin.com
1%

Frequently Asked Questions

Where is Diasorin Group's headquarters located?

Minus sign iconPlus sign icon
Diasorin Group's main headquarters is located at Saluggia, Piemonte 13040 Italy. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Diasorin Group's phone number?

Minus sign iconPlus sign icon
You can contact Diasorin Group's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Diasorin Group's stock symbol?

Minus sign iconPlus sign icon
Diasorin Group is a publicly traded company; the company's stock symbol is DSRLF.

What is Diasorin Group's official website and social media links?

Minus sign iconPlus sign icon
Diasorin Group's official website is diasorin.com and has social profiles on LinkedIn.

What is Diasorin Group's SIC code NAICS code?

Minus sign iconPlus sign icon
Diasorin Group's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Diasorin Group have currently?

Minus sign iconPlus sign icon
As of February 2026, Diasorin Group has approximately 2.6K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Ceo & General Manager: A. C.Cfo - Group Supply Chain & Procurement: P. P.Chief Information Security Officer: D. L.. Explore Diasorin Group's employee directory with LeadIQ.

What industry does Diasorin Group belong to?

Minus sign iconPlus sign icon
Diasorin Group operates in the Biotechnology Research industry.

What technology does Diasorin Group use?

Minus sign iconPlus sign icon
Diasorin Group's tech stack includes Open GraphWordPressOracle ERPBomgarSocial IntelligenceJSONMinitabApache HTTP Server.

What is Diasorin Group's email format?

Minus sign iconPlus sign icon
Diasorin Group's email format typically follows the pattern of First.Last@diasorin.com. Find more Diasorin Group email formats with LeadIQ.

Diasorin Group

Biotechnology ResearchPiemonte, Italy1001-5000 Employees

Headquartered in Italy and listed on the Italian Stock Exchange within the FTSE MIB Index, Diasorin is a global leader in the In Vitro Diagnostic (IVD) field and, since 2021, has been active in the Life Science business. For over 50 years, the Company has been developing, producing, and marketing reagent kits used by diagnostic laboratories worldwide.
The Group operates across five continents through 35 companies, 4 branches, 10 manufacturing facilities, and 9 research and development centers. Our extensive diagnostic testing and life science offering, continuously enhanced through significant investments in research, positions Diasorin as the player with the broadest range of specialty tests available in the diagnostic market, identifying the Group as “The Diagnostic Specialist.”
With a team of over 3,200 employees worldwide, including more than 400 researchers, we are committed to improving healthcare and enhancing people's quality of life. We value diversity, skills, and talent as key drivers of innovation and excellence, fostering an inclusive work environment that evolves alongside the ever-changing landscape of global healthcare.

Section iconCompany Overview

Headquarters
Saluggia, Piemonte 13040 Italy
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DSRLF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $500M$1B

    Diasorin Group's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Diasorin Group's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.